HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection.

Abstract
Multiple sclerosis is a chronic inflammatory disease of the CNS. Although progressive axonal injury and diffuse inflammatory damage has been shown in the chronic phase of the disease, little is known about the molecular mechanisms underlying these pathological processes. In order to identify these mechanisms, we have studied the gene expression profile in non-lesion containing tissue, the so-called normal-appearing white matter (NAWM). We performed differential gene expression analysis and quantitative RT-PCR on subcortical white matter from 11 multiple sclerosis and 8 control cases. Differentially expressed genes were further analysed in detail by in situ hybridization and immunofluorescence studies. We show that genes known to be involved in anti-inflammatory and protective mechanisms such as STAT6, JAK1, IL-4R, IL-10, Chromogranin C and Hif-1alpha are consistently upregulated in the multiple sclerosis NAWM. On the other hand, genes involved in pro-inflammatory mechanisms, such as STAT4, IL-1beta and MCSF, were also upregulated but less regularly. Immunofluorescence colocalization analysis revealed expression of STAT6, JAK1, IL-4R and IL-13R mainly in oligodendrocytes, whereas STAT4 expression was detected predominantly in microglia. In line with these data, in situ hybridization analysis showed an increased expression in multiple sclerosis NAWM of HIF-1alpha in oligodendrocytes and HLA-DRalpha in microglia cells. The consistency of the expression levels of STAT6, JAK1, JAK3 and IL-4R between the multiple sclerosis cases suggests an overall activation of the STAT6-signalling pathway in oligodendrocytes, whereas the expression of STAT4 and HLA-DRalpha indicates the activation of pro-inflammatory pathways in microglia. The upregulation of genes involved in anti-inflammatory mechanisms driven by oligodendrocytes may protect the CNS environment and thus limit lesion formation, whereas the activation of pro-inflammatory mechanisms in microglia may favour disease progression. Altogether, our data suggests an endogenous inflammatory reaction throughout the whole white matter of multiple sclerosis brain, in which oligodendrocytes actively participate. This reaction might further influence and to some extent facilitate lesion formation.
AuthorsThomas Zeis, Ursula Graumann, Richard Reynolds, Nicole Schaeren-Wiemers
JournalBrain : a journal of neurology (Brain) Vol. 131 Issue Pt 1 Pg. 288-303 (Jan 2008) ISSN: 1460-2156 [Electronic] England
PMID18056737 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Cell Adhesion Molecules
  • Chemokines
  • Cytokines
  • HIF1A protein, human
  • HLA-DR Antigens
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Inflammation Mediators
  • Receptors, Chemokine
  • Receptors, Cytokine
  • STAT6 Transcription Factor
  • STAT6 protein, human
  • Nitric Oxide Synthase
Topics
  • Aged
  • Brain (metabolism, pathology)
  • Cell Adhesion Molecules (genetics, metabolism)
  • Chemokines (biosynthesis, genetics)
  • Cytokines (biosynthesis, genetics)
  • Female
  • Gene Expression Profiling
  • HLA-DR Antigens (biosynthesis, genetics)
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (biosynthesis, genetics)
  • Inflammation Mediators (metabolism)
  • Male
  • Microglia (physiology)
  • Middle Aged
  • Multiple Sclerosis (metabolism, pathology)
  • Nitric Oxide Synthase (biosynthesis, genetics)
  • Oligodendroglia (physiology)
  • Oligonucleotide Array Sequence Analysis (methods)
  • Receptors, Chemokine (biosynthesis, genetics)
  • Receptors, Cytokine (biosynthesis, genetics)
  • Reverse Transcriptase Polymerase Chain Reaction (methods)
  • STAT6 Transcription Factor (metabolism)
  • Signal Transduction
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: